Impact of FIB‐4 index on hepatocellular carcinoma incidence during nucleos(t)ide analogue therapy in patients with chronic hepatitis B: An analysis using time‐dependent receiver operating characteristic

T. Tada,T. Kumada,H. Toyoda,K. Tsuji,A. Hiraoka,J. Tanaka
DOI: https://doi.org/10.1111/jgh.13473
2017-02-01
Journal of Gastroenterology and Hepatology
Abstract:Nucleos(t)ide analogue (NA) therapy has been reported to reduce the risk of hepatocellular carcinoma (HCC) development in patients with chronic hepatitis B (CHB). However, even during NA therapy, development of HCC has been observed in patients with CHB. Therefore, we clarified the predictive power of clinical factors for HCC incidence using receiver operating characteristic (ROC) analysis that takes time dependence into account.
What problem does this paper attempt to address?